Next Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$89K Sell
668
-536
-45% -$77K 0.01% 1219
2021
Q3
$165K Buy
1,204
+108
+10% +$13.6K 0.01% 928
2021
Q2
$117K Buy
1,096
+36
+3% +$3.46K 0.01% 1043
2021
Q1
$95K Sell
1,060
-152
-13% -$14.3K 0.01% 1050
2020
Q4
$112K Buy
1,212
+240
+25% +$21.4K 0.01% 920
2020
Q3
$100K Buy
+972
New +$102K 0.01% 859
2020
Q2
Sell
-1,852
Closed -$125K 912
2020
Q1
$125K Buy
1,852
+1,540
+494% +$95.8K 0.02% 688
2019
Q4
$17K Sell
312
-40
-11% -$1.9K ﹤0.01% 1582
2019
Q3
$13K Sell
352
-260
-42% -$10.1K ﹤0.01% 1602
2019
Q2
$23K Buy
+612
New +$19.2K ﹤0.01% 1408
2019
Q1
Sell
-4,248
Closed -$127K 1725
2018
Q4
$127K Buy
+4,248
New +$135K 0.03% 522
2016
Q3
Sell
-4
Closed 2383
2016
Q2
$0 Hold
4
﹤0.01% 1766
2016
Q1
$0 Hold
4
﹤0.01% 1760
2015
Q4
$0 Buy
+4
New +$83 ﹤0.01% 1812

Other funds holding DXCM

Next Financial Group's DXCM Position: Q4 2021 in Review

Next Financial Group reduced its DexCom (DXCM) stake by 45% in Q4 2021, selling an estimated $77K and leaving 668 shares worth $89K. The position accounts for 0.01% of the portfolio, ranked #1219.

Next Financial Group first reported a position in DXCM in Q4 2015 and has held it in 14 quarters since. The position peaked at $165K in Q3 2021. 930 funds tracked by Wall St. Rank hold DXCM as of Q4 2021.

  • Next Financial Group held 668 shares of DexCom worth $89K as of Q4 2021.
  • Next Financial Group sold 536 DexCom shares in Q4 2021, an estimated $77K.
  • DexCom made up 0.01% of Next Financial Group's portfolio in Q4 2021, its #1219 holding.
  • Next Financial Group first reported a position in DexCom in Q4 2015 and has held it in 14 quarters since.
  • Next Financial Group's DexCom position peaked at $165K in Q3 2021.
  • 930 funds tracked by Wall St. Rank held DexCom as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.